Opioid treatment for acute and chronic pain in patients with sickle cell disease

Research output: Contribution to journalReview article

Abstract

Sickle cell disease is a uniquely complex painful disease, with lifelong episodes of unpredictable acute pain and superimposed chronic pain in adulthood. Both painful crises and chronic pain in sickle cell disease lack strong objective pathological correlates and their mechanisms are poorly understood. Opioids have emerged as the standard of care for severe acute pain in sickle cell disease and many patients with chronic pain are maintained on chronic opioid therapy. The strong association between recurrent acute pain and chronic pain in SCD blurs the distinction between acute and chronic opioid management paradigms. In addition, opioid management for SCD is dogged by stigma and concerns regarding addiction. This review aims to synthesize the broad literature on opioids to highlight the clinical complexity of opioid management in sickle cell disease and suggest directions for future research and clinical innovation.

Original languageEnglish (US)
Article number134534
JournalNeuroscience Letters
Volume714
DOIs
StatePublished - Jan 1 2020

Fingerprint

Acute Pain
Sickle Cell Anemia
Chronic Pain
Opioid Analgesics
Therapeutics
Standard of Care

Keywords

  • Chronic pain
  • Opioids
  • Sickle cell disease

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Opioid treatment for acute and chronic pain in patients with sickle cell disease. / Carroll, C. Patrick.

In: Neuroscience Letters, Vol. 714, 134534, 01.01.2020.

Research output: Contribution to journalReview article

@article{a79f8483694c45fdb0b64dc9c70ba5a3,
title = "Opioid treatment for acute and chronic pain in patients with sickle cell disease",
abstract = "Sickle cell disease is a uniquely complex painful disease, with lifelong episodes of unpredictable acute pain and superimposed chronic pain in adulthood. Both painful crises and chronic pain in sickle cell disease lack strong objective pathological correlates and their mechanisms are poorly understood. Opioids have emerged as the standard of care for severe acute pain in sickle cell disease and many patients with chronic pain are maintained on chronic opioid therapy. The strong association between recurrent acute pain and chronic pain in SCD blurs the distinction between acute and chronic opioid management paradigms. In addition, opioid management for SCD is dogged by stigma and concerns regarding addiction. This review aims to synthesize the broad literature on opioids to highlight the clinical complexity of opioid management in sickle cell disease and suggest directions for future research and clinical innovation.",
keywords = "Chronic pain, Opioids, Sickle cell disease",
author = "Carroll, {C. Patrick}",
year = "2020",
month = "1",
day = "1",
doi = "10.1016/j.neulet.2019.134534",
language = "English (US)",
volume = "714",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Opioid treatment for acute and chronic pain in patients with sickle cell disease

AU - Carroll, C. Patrick

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Sickle cell disease is a uniquely complex painful disease, with lifelong episodes of unpredictable acute pain and superimposed chronic pain in adulthood. Both painful crises and chronic pain in sickle cell disease lack strong objective pathological correlates and their mechanisms are poorly understood. Opioids have emerged as the standard of care for severe acute pain in sickle cell disease and many patients with chronic pain are maintained on chronic opioid therapy. The strong association between recurrent acute pain and chronic pain in SCD blurs the distinction between acute and chronic opioid management paradigms. In addition, opioid management for SCD is dogged by stigma and concerns regarding addiction. This review aims to synthesize the broad literature on opioids to highlight the clinical complexity of opioid management in sickle cell disease and suggest directions for future research and clinical innovation.

AB - Sickle cell disease is a uniquely complex painful disease, with lifelong episodes of unpredictable acute pain and superimposed chronic pain in adulthood. Both painful crises and chronic pain in sickle cell disease lack strong objective pathological correlates and their mechanisms are poorly understood. Opioids have emerged as the standard of care for severe acute pain in sickle cell disease and many patients with chronic pain are maintained on chronic opioid therapy. The strong association between recurrent acute pain and chronic pain in SCD blurs the distinction between acute and chronic opioid management paradigms. In addition, opioid management for SCD is dogged by stigma and concerns regarding addiction. This review aims to synthesize the broad literature on opioids to highlight the clinical complexity of opioid management in sickle cell disease and suggest directions for future research and clinical innovation.

KW - Chronic pain

KW - Opioids

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=85074201214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074201214&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2019.134534

DO - 10.1016/j.neulet.2019.134534

M3 - Review article

C2 - 31593753

AN - SCOPUS:85074201214

VL - 714

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

M1 - 134534

ER -